Molecular Epidemiology of Biliary Tree Cancers

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT05179486
Status
Recruiting
Apply to this trial

Conditions

  • Cholangiocarcinoma
  • Malignant Digestive System Neoplasm

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Biospecimen Collection — PROCEDURE
    Undergo collection of tissue, and blood
  • Questionnaire Administration — OTHER
    Complete questionnaire

Study Details

This study is to learn if certain risk factors (environmental, viral, behavioral, medical, and dietary), tumor markers, and genetic changes can predict the development and outcome of biliary tree cancers. Establishing biomarkers models from patients may help doctors to further understand how biliary tree cancer is affected by different treatments, and why some people's cancer responds differently than others.

Key Dates

Start date
Sep 25, 2017
Status verified
Apr 2026
Primary completion
Feb 2, 2027
Completion
Feb 2, 2027

Study Design

Enrollment
1,500 participants (estimated)

Arms

  • Arm: Observational (biospecimen collection, questionnaire)
    Participants complete a questionnaire over 20 minutes. Participants also undergo collection of blood and leftover tissue samples.

Primary Outcome Measure

Significant factors that may contribute to the etiology of biliary tree cancer [ Time Frame: through study completion, an average of 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
M D Anderson Cancer CenterHoustonTexas77030
Manal M Hassan
[email protected]
713-794-5452
Manal M Hassan (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By research site
M D Anderson Cancer Center· Houston, TX

Related Studies